Control group:Coventional Treatment

2 trials

Sponsors

Shanghai University of TCM

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Early Phase 1

A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19)

RecruitingITMCTR2000003077

Shanghai University of TCMNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-27Updated: 2023-02-20

A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19)

RecruitingChiCTR2000030469

Shanghai University of TCMNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-27Updated: 2020-03-09